PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
8.16%
Net income growth at 75-90% of MCHP's 10.04%. Bill Ackman would call for strategic or operational tweaks to match competitor’s earnings growth.
-4.22%
Both reduce yoy D&A, with MCHP at -0.88%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
66.40%
Some yoy growth while MCHP is negative at -298.16%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-14.29%
Negative yoy SBC while MCHP is 2.07%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
1.48%
Less working capital growth vs. MCHP's 602.89%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
269.39%
AR growth while MCHP is negative at -221.00%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-73.53%
Both reduce yoy inventory, with MCHP at -65.78%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
555.56%
AP growth well above MCHP's 281.65%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-89.35%
Negative yoy usage while MCHP is 266.98%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-2485.71%
Both negative yoy, with MCHP at -34.13%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-1.84%
Both yoy CFO lines are negative, with MCHP at -3.75%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
20.86%
CapEx growth well above MCHP's 7.82%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-20.86%
Negative yoy acquisition while MCHP stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-36.20%
Negative yoy purchasing while MCHP stands at 92.80%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
48.54%
Below 50% of MCHP's 310.03%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
15.71%
Growth well above MCHP's 15.74%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-13.60%
We reduce yoy invests while MCHP stands at 3034.95%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-107.79%
Negative yoy issuance while MCHP is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
5.00%
Buyback growth below 50% of MCHP's 100.00%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.